Yeah I fear that my wife was right on this one and I should have bailed when I was only a couple thousand down. I really trusted these guys that they really were industry leaders and had a clue how to run a business. I hope something happens where I can get out of this without too much of a loss, but I'm skeptical that it's going to happen. The R/S is just going to let them dilute more, and give more ammo for anyone potentially manipulating the stock to do it even more. I honestly can't fathom how these "industry leader" management types are so freaking clueless as to how they are negatively affecting their stock. Well, like I've said before, they don't care. They are covering themselves so they won't experience the loss we are taking, and therefore they have zero motivation to improve the PPS because it's not affecting them, just us fools who put our trust in their capability to successfully run a company and make the right decisions.
Yeah I fear that my wife was right on this one and I should
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Investors Monitor Class Action Against Xerox Ahead of Deadline
Xerox Holdings Corporation Under Legal Scrutiny Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors of Xerox Holdings Corporation (NASDAQ: XRX) to inform them about an ongoing class action lawsuit. Investors are reminded of an important deadline for those wanting to assume the role of lead plaintiff in this case. The deadline for...
Continue Reading
UBS's Caution on Dr. Reddy's Projections Signals Concerns
UBS dropped a Sell rating on Dr. Reddy's Laboratories (NSE: DRRD) back in 2024, tagging the stock with a price target of INR 5,700.00. You could feel the tension shift in trading rooms as their assessment sparked fresh chatter about the firm’s US base business revenue projections that seem downright optimistic. UBS Questions Revenue Estimates: Too High or Just Right?...
Continue Reading
Evaluating Apple's Business Landscape Among Top Tech Firms
Assessing Market Position and Performance In the dynamic world of technology hardware, it’s crucial for investors to analyze the competition thoroughly. This article takes a closer look at Apple (NASDAQ: AAPL) and compares its financial metrics and market position against its key competitors in the industry. With this analysis, we aim to provide insights into Apple's...
Continue Reading
Back to School: Parents Prepare for Illness and Solutions
Back to School: Parents Brace for Sickness A recent survey shows that as children head back to the classroom, many parents anticipate facing a wave of illnesses at home. Conducted by Boiron, a leader in homeopathic remedies, this nationwide survey reveals parents' concerns about the inevitable germs that come along with the school year. Survey Insights on Parental...
Continue Reading
Scarf Systems Achieves SOC 2 Type 2 Examination Success
Scarf Systems, Inc. completed a SOC 2 Type 2 examination back in early 2023, solidifying its place as a frontrunner in data security. This wasn't just some routine check; it was a deep dive into how well Scarf protected customer data and adhered to stringent safety protocols. But here’s the kicker—traders started asking: is this enough to keep investors calm? What’s...
Continue Reading